Gargi & Emma's Notes - Gynae Flashcards
What is vulval cancer?
Cancer of the vulva (external genitalia)
What is the aetiology of vulval cancer?
90% are squamous cell carcinomas; remainder are malignant melanoma, basal cell carcinoma and adenocarcinoma of the Bartholin gland
Squamous cell carcinoma has 2 aetiologies:
- HPV-associated: arise on a background of high-grade vulval intraepithelial neoplasia (VIN3); affects younger women
→ VIN: multifocal leukoplakic, erythematous or pigmented lesions caused by high-risk HPV; 10% risk of malignancy - Non-HPV associated: associated with lichen sclerosus; affects older women
- Spread is local, then lymphatic spread via inguinofemoral and pelvic lymph nodes
How is vulval cancer staged?
Staging (FIGO):
-
Stage 1: tumour confined to vulva/perineum, negative nodes
- 1A: ≤2cm in size, stromal invasion ≤1mm
- 1B: >2cm in size or stromal invasion >1mm
- Stage 2: tumour of any size extending to lower 1/3 of urethra or vagina, or anus, negative nodes
-
Stage 3: as for stage 2, but positive inguinofemoral lymph nodes
- 3A1: 1 lymph node metastasis ³5mm
- 3A2: 1-2 lymph node metastases <5mm
- 3B1: ³2 lymph node metastases ³5mm
- 3B2: ³3 lymph node metastases <5mm
- 3C: extracapsular spread
-
Stage 4: regional or distant spread
- 4A1: upper urethra/vaginal mucosa, bladder or rectal mucosa, fixed to pelvic bone
- 4A2: fixed or ulcerated inguinofemoral lymph nodes
- 4B: distant metastases, including pelvic lymph nodes
What are the symptoms of vulval cancer?
- Vulval lump/swelling/ulcer
- May be itchy or painful
- Bleeding or discharge
- May have inguinal lymphadenopathy (hard, craggy, fixed subcutaneous swellings)
- May have associated pre-malignant disease
- VIN may be asymptomatic, or itchy/irritated
What are the Ix for ?vulval cancer?
- Examination of external genitalia
- Biopsy
- To confirm diagnosis
- Cervical smear
- If VIN-associated; to exclude CIN
- Bloods: FBC, U&Es
- Staging: cystoscopy, proctoscopy, CT CAP, MRI (LN involvement), CXR
What is the Mx of vulval cancer?
Specialist gynae oncology MDT approach (gynae onc surgeons, radiologists, histopathologists, specialist nurses)
Surgery:
- Early-stage disease: wide radical local excision +/- inguinofemoral lymphadenectomy
- Clear margin of >10mm is ideal (difficult if close proximity to urethra/anus)
- Sentinel LN biopsy may be done to determine whether full lymphadenectomy is needed
- Large/multifocal lesions: radical vulvectomy +/- inguinofemoral lymphadenectomy
- May need vulval reconstruction
Radiotherapy:
- External-beam radiation
- Adjuvant treatment after surgery if excision margins are small; neoadjuvant for large tumours that are close to anus/urethra (to shrink before surgery); advanced disease or when surgery is not possible
What are the complications of vulval cancer?
Complications:
- Psychosexual implications
- Surgical complications: wound breakdown, infection, chronic lymphoedema (if lymphadenectomy
What is the prognosis of vulval cancer?
May present late due to embarrassment
- 5-year survival: stage 1: 90%; stage 2: 50%; stage 3: 30%; stage 4: 15%
N.B. VIN may resolve spontaneously, or takes 10yrs to progress to cancer
What is the aetiology of cervical cancer?
70% are squamous cell carcinomas; 15% adenocarcinoma; 15% mixed
Develops as a progression from CIN, which takes 10-20 years
- Not all CIN progresses to cancer
- Invasive cervical cancer occurs when the basement membrane of the epithelium has been breached
- Spread is direct to parametria (lateral to cervix), bladder, vagina and rectum; metastases via lymphatics (pelvic and para-aortic LNs to liver and lungs)
What are the risk factors for cervical cancer?
- HPV infection,
- smoking,
- other STIs,
- immunodeficiency
How is cervical cancer staged?
Staging (FIGO):
-
Stage 1: tumour confined to cervix
- 1A: microscopic disease
- 1A1: maximum horizontal dimension 7mm and depth 3mm
- 1A2: maximum horizontal dimension 7mm and depth 3-5mm
- 1B: clinical lesions confined to cervix or preclinical lesions greater than 1A
- 1B1: clinical lesions <4cm in size
- 1B2: clinical lesions >4cm in size
- 1A: microscopic disease
-
Stage 2: tumour extends beyond the cervix and involves vagina (not lower 1/3) and/or parametrium (not reaching pelvic side wall)
- 2A: tumour involves vagina
- 2B: tumour involves parametrium
-
Stage 3: tumour involves lower 1/3 of vagina and/or extends to pelvic side wall
- 3A: tumour involves lower 1/3 of vagina
- 3B: tumour extends to pelvic wall and/or causes hydronephrosis/non-functioning kidney
-
Stage 4: further spread
- 4A: tumour involves bladder or rectum and/or extends beyond true pelvis
- 4B: spread to distant organs
What are the symptoms of cervical cancer?
- May be asymptomatic → incidental finding on LLETZ for CIN
- Abnormal vaginal bleeding → PCB, IMB, PMB
- Dyspareunia, pelvic pain
- Vaginal discharge (mucoid/purulent)/blood stained)
- Late symptoms (from mets): black pain (spread to spinal cord), anaemia (chronic vaginal bleeding), renal failure (ureteric blockage), incontinence (vesicovaginal fistulae), haematuria, pressure symptoms
What may be seen O/E in cervical cancer?
- On examination:
- Speculum: macroscopic tumour/discolouration/ulceration/erosion on cervix; may bleed on contact
- Vaginal/abdo: mass (if pelvic spread)
- Chest: possible pulmonary mets
What are the Ix for ?cervical cancer?
- Speculum, bimanual, abdo, chest examinations
-
Colposcopy and biopsy (<2wks)
- Confirms diagnosis, identifies subtype
If the diagnosis of cervical cancer is confirmed:
- Basic bloods: FBC (anaemia), LFTs (liver/bone involvement), U&Es (renal involvement)
- Staging: CXR, cystoscopy, barium enema/proctoscopy, CT CAP, MRI, PET etc
N.B. cervical smears detect CIN, not cancer
What is the Mx of cervical cancer?
MDT approach
Depends on stage of disease and requirement for future fertility
Surgery:
- Stage 1A1 (micro-invasive): cone biopsy excision; remove co-existing CIN
- Allows fertility to be preserved
- Stage 1A2-2A (early stage): radical hysterectomy + lymphadenectomy
- Usually laparotomy (laparoscopic has lower survival rates)
- Radical trachelectomy considered if fertility is desired (removal of cervix and upper part of vagina) + lymphadenectomy
Chemoradiotherapy:
- External beam radiation/brachytherapy + cisplatin-based chemotherapy
- Indications:
- Stage 1A1-1B1 if positive margins/positive nodes (postoperatively)
- Instead of surgery if tumours >4cm (1B2, 2A2)
- Locally advanced or metastatic disease (2B and above)
- Surgery is not attempted because unlikely to remove all of the tumour
Recurrent tumours:
- Chemo-radiotherapy if not already given
- Pelvic extenteration (removal of vagina, uterus, cervix, bladder and rectum)
Palliative therapy if it is not possible to offer curative treatment